Psilocybin Produces Substantial and Sustained Decreases in Depression and Anxiety in Patients with Life-threatening Cancer: A Randomized Double-blind Trial

Overview

Journal J Psychopharmacol

Publisher Sage Publications

Specialty Pharmacology

Date 2016 Dec 3

PMID 27909165

Citations 557

Authors

Roland R Griffiths

Matthew W Johnson

Michael A Carducci

Annie Umbricht

William A Richards

Brian D Richards

Mary P Cosimano

Margaret A Klinedinst

Affiliations

Soon will be listed here.

Abstract

Trial Registration: ClinicalTrials.gov identifier: NCT00465595.

Citing Articles

Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.

Belitzky E, Ravani Carvalho L, Taylor M, Ortiz C, Baum L, Fiellin D Cancer Med. 2025; 14(5):e70586.

PMID: 40052631 PMC: 11886891. DOI: 10.1002/cam4.70586.

Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic.

Hibicke M, Billac G, Nichols C Psychedelic Med (New Rochelle). 2025; 2(1):10-14.

PMID: 40051761 PMC: 11658646. DOI: 10.1089/psymed.2023.0037.

The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.

Strickland J, Garcia-Romeu A, Johnson M Psychedelic Med (New Rochelle). 2025; 2(1):33-43.

PMID: 40051759 PMC: 11658653. DOI: 10.1089/psymed.2023.0046.

Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence.

Dames S, Watler C, Kryskow P, Allard P, Gagnon M, Taylor W Psychedelic Med (New Rochelle). 2025; 2(3):130-137.

PMID: 40051685 PMC: 11658659. DOI: 10.1089/psymed.2023.0004.

The Therapeutic Potential of Psychedelics on Reducing Rumination: A Mini-Review.

Ramarushton B, Blumenthal H, Ryals A, Boals A, Thompson L Psychedelic Med (New Rochelle). 2025; 2(3):146-152.

PMID: 40051683 PMC: 11658672. DOI: 10.1089/psymed.2024.0009.

References

Strassman R, Qualls C, Uhlenhuth E, Kellner R . Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry. 1994; 51(2):98-108. DOI: 10.1001/archpsyc.1994.03950020022002. View

Spiegel D . Existential Psychotherapy for Patients With Advanced Cancer: Facing the Future and the Past. J Clin Oncol. 2015; 33(24):2713-4. DOI: 10.1200/JCO.2015.62.2365. View

Carhart-Harris R, Bolstridge M, Rucker J, Day C, Erritzoe D, Kaelen M . Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry. 2016; 3(7):619-27. DOI: 10.1016/S2215-0366(16)30065-7. View

Vollenweider F, Kometer M . The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci. 2010; 11(9):642-51. DOI: 10.1038/nrn2884. View

Hendricks P, Johnson M, Griffiths R . Psilocybin, psychological distress, and suicidality. J Psychopharmacol. 2015; 29(9):1041-3. PMC: 4721603. DOI: 10.1177/0269881115598338. View

Carhart-Harris R, Erritzoe D, Williams T, Stone J, Reed L, Colasanti A . Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A. 2012; 109(6):2138-43. PMC: 3277566. DOI: 10.1073/pnas.1119598109. View

Scheier M, Carver C . Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol. 1985; 4(3):219-47. DOI: 10.1037//0278-6133.4.3.219. View

Gao K, Wu R, Kemp D, Chen J, Karberg E, Conroy C . Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial. J Clin Psychiatry. 2014; 75(10):1062-8. DOI: 10.4088/JCP.13m08847. View

Prieto J, Blanch J, Atala J, Carreras E, Rovira M, Cirera E . Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002; 20(7):1907-17. DOI: 10.1200/JCO.2002.07.101. View

10.

Dittrich A . The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry. 1998; 31 Suppl 2:80-4. DOI: 10.1055/s-2007-979351. View

11.

Studerus E, Kometer M, Hasler F, Vollenweider F . Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol. 2010; 25(11):1434-52. DOI: 10.1177/0269881110382466. View

12.

Carhart-Harris R, Leech R, Hellyer P, Shanahan M, Feilding A, Tagliazucchi E . The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci. 2014; 8:20. PMC: 3909994. DOI: 10.3389/fnhum.2014.00020. View

13.

Mitchell A, Chan M, Bhatti H, Halton M, Grassi L, Johansen C . Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011; 12(2):160-74. DOI: 10.1016/S1470-2045(11)70002-X. View

14.

Shim E, Park J . Suicidality and its associated factors in cancer patients: results of a multi-center study in Korea. Int J Psychiatry Med. 2012; 43(4):381-403. DOI: 10.2190/PM.43.4.g. View

15.

Johnson M, Sewell R, Griffiths R . Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug Alcohol Depend. 2011; 123(1-3):132-40. PMC: 3345296. DOI: 10.1016/j.drugalcdep.2011.10.029. View

16.

Arrieta O, Angulo L, Nunez-Valencia C, Dorantes-Gallareta Y, Macedo E, Martinez-Lopez D . Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2012; 20(6):1941-8. DOI: 10.1245/s10434-012-2793-5. View

17.

Shear M, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto M . Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 2001; 13(4):166-78. View

18.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

19.

Nichols D . Psychedelics. Pharmacol Rev. 2016; 68(2):264-355. PMC: 4813425. DOI: 10.1124/pr.115.011478. View

20.

Walker J, Sawhney A, Holm Hansen C, Ahmed S, MARTIN P, Symeonides S . Treatment of depression in adults with cancer: a systematic review of randomized controlled trials. Psychol Med. 2013; 44(5):897-907. DOI: 10.1017/S0033291713001372. View